A Randomized, Single-blind, Comparison Trial of Beractant (BeraksurfTM) versus Poractant Alfa (Curosurf®) in the Treatment of Respiratory Distress Syndrome in Preterm Infants

• Main Authors: Manizheh Mostafa Gharehbaghi (Author), Parvin Sarbakhsh (Author), Hossein Mohammadbager (Author), Safoora Gharibzadeh (Author), Elnaz Shaseb (Author)
• Formato: Livro
• Publicado em: Tabriz University of Medical Sciences, 2023-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Neonatal respiratory distress syndrome (NRDS) affects approximately up to 7% of all term newborns. This study aimed to assess the efficacy and safety of investigational beractant (BeraksurfTM, Tekzima Company) in comparison with poractant alfa (Curosurf®, Chiesi Pharmaceuticals) as surfa...